RxSight, Inc. RXST
4.66
(0.07)
(1.48%)
as of 25 Sep
- Market cap
- $196.7M
- P/E
- 0.0×
Follow RXST
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
3.17 | 9.55 | 14.18 | 7.21 | 6.78 | 4.31 | 4.31 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(381.42) | (313.68) | (152.12) | (25.52) | (17.57) | (5.48) | (5.48) | — |
P/B ratio |
1.54 | 4.75 | 7.87 | 3.93 | 1.11 | 0.00 | 0.00 | — |
Price to Tangible BV |
1.54 | 4.75 | 7.87 | 3.93 | 1.11 | 0.00 | 0.00 | — |
EV/Sales |
1.48 | 7.86 | 12.76 | 5.87 | 1.49 | 2.85 | 2.85 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(12.82) | (64.94) | (27.34) | (4.89) | (0.75) | (1.16) | (1.16) | — |
EV/FCF |
(10.28) | (49.16) | (24.50) | (4.70) | (0.72) | (1.09) | (1.09) | — |
Quick Ratio |
9.58 | 10.33 | 7.05 | 6.77 | 14.82 | 6.19 | 9.63 | — |
Current Ratio |
10.95 | 11.36 | 8.06 | 7.81 | 15.92 | 7.03 | 10.67 | — |
Net Debt/EBITDA |
4.27 | 5.61 | 2.45 | 1.09 | 2.47 | 1.40 | 1.76 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 26.75% | 20.63% | 24.23% | 4.99% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.45 | 0.29 | 9.08 | 0.24 | — |
Asset Turnover |
0.43 | 0.56 | 0.54 | 0.29 | 0.15 | 0.14 | 0.04 | — |
Operating CF/Net income |
0.40 | 0.62 | 0.86 | 0.88 | 0.92 | (10.46) | (1.55) | — |
Capex/Depreciation |
0.73 | 1.01 | 2.74 | (0.76) | (0.44) | (0.69) | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (13.99%) | (12.43%) | (38.85%) | (58.52%) | 45.85% | (1.03%) | 0.00% | — | |
| (12.36%) | (10.96%) | (29.22%) | (38.94%) | (33.19%) | 3.19% | 47.32% | — | |
ROIC |
(63.34%) | (52.34%) | (94.34%) | (163.06%) | (176.71%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(14.20%) | (9.79%) | (30.70%) | (52.38%) | (27.60%) | 4.05% | 25.87% | — |
Average Days of Receivables |
63.47 | 78.39 | 83.10 | 81.60 | 78.55 | 71.24 | 128.51 | — |
Research and Development Expense of Revenue |
28.67% | 24.56% | 32.61% | 53.02% | 108.44% | 149.43% | 1,319.46% | — |
Selling, General and Administrative Expense of Revenue |
83.77% | 72.49% | 83.97% | 119.71% | 145.20% | 103.39% | 678.40% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
23.51% | 17.61% | 17.68% | 23.26% | 33.53% | 28.51% | 0.00% | — |
Graham Net Nets |
0.59 | 0.19 | 0.12 | 0.21 | 0.79 | 0.31 | 0.31 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(9.12%) | (2.09%) | (3.90%) | (18.94%) | (55.49%) | (55.49%) | (55.49%) | — |
Free Cash Flow Yield |
(4.54%) | (1.68%) | (3.67%) | (17.32%) | (30.43%) | (60.68%) | (60.68%) | — |
Revenue per Share |
3.29 | 3.60 | 2.59 | 1.77 | 1.66 | 3.96 | 0.08 | — |
Operating CF per Share |
(0.38) | (0.44) | (1.21) | (2.13) | (3.28) | (9.50) | (1.47) | — |
Capex per Share |
(0.09) | (0.14) | (0.14) | (0.09) | (0.14) | (0.68) | 0.00 | — |
Free Cash Flow per Share |
(0.47) | (0.58) | (1.35) | (2.21) | (3.42) | (10.18) | (1.47) | — |
Cash per Share |
5.58 | 6.10 | 3.69 | 3.82 | 11.69 | 18.61 | 2.92 | — |
Shareholders Equity per Share |
6.75 | 7.24 | 4.65 | 3.25 | 10.15 | 0.72 | 0.83 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
6.75 | 7.24 | 4.65 | 3.25 | 10.15 | 0.72 | 0.83 | — |
Free Cash Flow |
(19.34) | (22.39) | (46.41) | (61.24) | (46.65) | (37.74) | (40.62) | — |
Working Capital |
261.21 | 267.95 | 147.50 | 117.32 | 165.22 | 69.90 | 81.74 | — |
Capital Expenditures |
(3.83) | (5.44) | (4.81) | (2.39) | (1.94) | (2.54) | (4.09) | — |
Net Current Asset Value |
251.33 | 256.50 | 146.22 | 74.29 | 121.82 | (16.49) | 2.74 | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.03 | 0.04 | 0.05 | 0.05 | 0.09 | 0.17 | 0.00 | — |
Net Profit Margin |
(28.96%) | (19.62%) | (54.57%) | (136.22%) | (215.50%) | 22.93% | 1,165.86% | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
(0.40) | (0.44) | (0.16) | 0.31 | 0.40 | 0.27 | 0.20 | — |
Cash ROIC |
(5.67%) | (5.66%) | (18.24%) | (29.25%) | (16.58%) | (50.48%) | (54.85%) | — |
Accounts Receivable Turnover |
5.03 | 5.56 | 5.70 | 6.20 | 5.85 | 8.03 | 0.00 | — |
Accounts Payable Turnover |
6.40 | 9.75 | 10.94 | 12.92 | 12.81 | 7.78 | 0.00 | — |
Inventory Turnover |
1.18 | 2.08 | 2.19 | 2.42 | 2.22 | 1.67 | 0.00 | — |
Average Days of Payables |
61.42 | 40.47 | 39.93 | 34.22 | 34.11 | 31.91 | 197.69 | — |
Days of Inventory on Hand |
366.03 | 196.01 | 180.07 | 195.64 | 162.19 | 233.19 | 649.00 | — |
Average Receivables |
26.72 | 25.17 | 15.62 | 7.91 | 3.86 | 1.83 | — | — |
Average Payables |
4.92 | 4.20 | 3.23 | 2.14 | 1.41 | 1.67 | — | — |
Average Inventory |
26.78 | 19.72 | 16.13 | 11.43 | 8.16 | 7.75 | — | — |
Average Assets |
315.19 | 250.56 | 166.36 | 171.44 | 146.70 | 105.55 | 55.22 | — |
Average Common Equity |
278.46 | 220.80 | 125.13 | 114.07 | (106.19) | (327.61) | — | — |
Columns are period end dates